Preferred Name | Flecainide | |
Synonyms |
FLECAINIDE Flecainide flecainide |
|
Definitions |
A synthetic agent derived from trifluoroethoxy-benzamide exhibiting antiarrhythmic and local anesthetic activity. As a class Ic antiarrhythmic that blocks sodium channels, flecainide depresses polarization phase 0 and decreases the induction velocity of the His-Purkinje system. It also decreases phase 4 slope and increases the depolarization threshold. (NCI04) |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62029 |
|
ALT_DEFINITION |
A drug that is used to treat abnormal heart rhythms. It may also relieve neuropathic pain, the burning, stabbing, or stinging pain that may arise from damage to nerves caused by some types of cancer or cancer treatment. |
|
CAS_Registry |
54143-55-4 |
|
Chemical_Formula |
C17H20F6N2O3 |
|
code |
C62029 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A synthetic agent derived from trifluoroethoxy-benzamide exhibiting antiarrhythmic and local anesthetic activity. As a class Ic antiarrhythmic that blocks sodium channels, flecainide depresses polarization phase 0 and decreases the induction velocity of the His-Purkinje system. It also decreases phase 4 slope and increases the depolarization threshold. (NCI04) |
|
FDA_UNII_Code |
K94FTS1806 |
|
FULL_SYN |
FLECAINIDE Flecainide flecainide |
|
Has_Salt_Form | ||
label |
Flecainide |
|
Legacy Concept Name |
Flecainide_Base |
|
Preferred_Name |
Flecainide |
|
prefixIRI |
Thesaurus:C62029 |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0016229 |
|
subClassOf |